Document:

EX-10.4

 Exhibit 10.4 

HISTOGENICS CORPORATION 

830 Winter Street 

Waltham, MA 02451 

March 19, 2019 
 Dear Stephen: 

This letter (the “Agreement”) is to confirm the agreement between you and Histogenics Corporation (the “Company”) in
connection with the termination of your employment with the Company. 
  

	 	1.	 Termination Date. Your employment with the Company will terminate on March 22, 2019 (the
“Termination Date”). On or prior to the Termination Date, you and the Company shall execute the Consulting Agreement attached hereto as Exhibit A. 

 

	 	2.	 Effective Date and Revocation. You have up to 21 days after you receive this Agreement to review it (the
“Release Deadline”). You are advised to consult an attorney of your own choosing before signing this Agreement. Furthermore, you have up to seven days after you sign this Agreement to revoke it. If you wish to revoke this Agreement after
signing it, you may do so by delivering a letter of revocation to me. If you do not revoke this Agreement, the eighth day after the date you sign it will be the “Effective Date.” Because of the
seven-day revocation period, no part of this Agreement will become effective or enforceable until the Effective Date. 

  

	 	3.	 Salary and Vacation Pay. On the Termination Date, the Company paid you $26,057.80, less all applicable
withholdings. This amount represents all of your unpaid salary earned through the Termination Date and all of your accrued but unused vacation time or PTO and unpaid expenses. You acknowledge that the only payments and benefits that you are entitled
to receive from the Company in the future are those specified in this Agreement. 

  

	 	4.	 Severance Pay. 

 

	 	(a)	 Pursuant to the terms set forth in your amended and restated employment agreement with the Company effective
October 10, 2017, the Company is obligated to pay you an amount equal to your current base salary for a period of nine months after the Termination Date in accordance with the Company’s standard payroll procedures, starting after the
Effective Date. The aggregate amount of these severance payments equals $293,906, less all applicable withholdings. However, the Company has determined that it is in its best interest to pay you such severance payments in a lump sum amount and the
full amount of $293,906, less all applicable withholdings, will be paid to you within 30 days of the Release Deadline. If you breach any provision of this Agreement, you understand that no unpaid severance payments will be made; however, in such
event this Agreement shall remain in full force and effect. 

  

	 	(b)	 Additionally, pursuant to the terms of the Amended and Restated Executive Retention Bonus Plan dated
January 25, 2019, you will be paid an aggregate of $156,750, less applicable withholdings, within 30 days of the Release Deadline. 

 Dr. Kennedy 
 
Page
 2
 
  

	 	5.	 COBRA Premiums. You will receive information about your right to continue your group health insurance
coverage under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”) after the Termination Date. In order to continue your coverage, you must file the required election form. If you sign and do not revoke this Agreement and elect to
continue group health insurance coverage, then the Company will pay the employer portion of the monthly premium under COBRA for you and, if applicable, your dependents until the earliest of (a) 9 months after the Termination Date, (b) the
expiration of your continuation coverage under COBRA or (c) the date when you receive substantially equivalent health insurance coverage in connection with new employment or self-employment. 

 

	 	6.	 Stock Options. The Company granted you options (the “Options”) to purchase up to 421,867
shares of the Company’s Common Stock on terms and conditions specified in certain Notice of Stock Option Awards and Stock Option Agreements (the “Option Agreements”). As of the Termination Date, the Options are vested with respect to
239,052 shares. Pursuant to the terms of the Option Agreements, the Options shall terminate with respect to all unvested shares as of the Termination Date and, unless exercised in accordance with the terms of the Option Agreements prior to such
time, the Options shall terminate with respect to all vested shares on the date that is 90 days after the Termination Date. You acknowledge and agree that you have no stock or equity rights of any kind in the Company except as described under this
Section 6. 

  

	 	7.	 Release of All Claims. In consideration for the severance and COBRA payments described in Paragraphs 4
and 5 above, to the fullest extent permitted by law, you waive, release and promise never to assert any claims or causes of action, whether or not now known, against the Company or its predecessors, successors or past, present or future
subsidiaries, stockholders, directors, officers, employees, consultants, attorneys, agents, assigns, insurers and employee benefit plans and their administrators and fiduciaries with respect to any matter, including (without limitation) any matter
related to your employment with the Company or the termination of that employment, including (without limitation) claims to attorneys’ fees or costs, claims of wrongful discharge, constructive discharge, emotional distress, defamation, invasion
of privacy, fraud, breach of contract (express or implied) or breach of the covenant of good faith and fair dealing, claims of discrimination, harassment retaliation and/or civil rights, claims relating to wages or compensation, claims under M.G.L.
c. 149, §§148 and 150 (also known as the Massachusetts Wage Act), claims under Title VII of the Civil Rights Act of 1964, the Massachusetts Fair Employment Practices Act, the California Fair Employment and Housing Act, the Age
Discrimination in Employment Act of 1967, the Americans with Disabilities Act and all other laws and regulations relating to employment. However, this release covers only those claims that arose prior to the execution of this Agreement and only
those claims that may be waived by applicable law. Execution of this Agreement does not bar any claim that arises hereafter, including (without limitation) a claim for breach of this Agreement. 

 Dr. Kennedy 
 
Page
 3
 
  

	 	8.	 Waiver. You expressly waive and release any and all rights and benefits under Section 1542 of the
California Civil Code (or any analogous law of any other state), which reads as follows: 

 A general release does not
extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor. 

 

	 	9.	 No Admission. Nothing contained in this Agreement will constitute or be treated as an admission by you
or the Company of liability, any wrongdoing or any violation of law. 

  

	 	10.	 Other Agreements. At all times in the future, you will remain bound by your Proprietary Information,
Inventions and Non-Solicitation Agreement with the Company, a copy of which is attached as Exhibit A. Except as expressly provided in this Agreement and the Consulting Agreement, this Agreement renders
null and void all prior agreements between you and the Company and constitutes the entire agreement between you and the Company regarding the subject matter of this Agreement. This Agreement may be modified only in a written document signed by you
and a duly authorized officer of the Company. 

  

	 	11.	 Confidentiality of Agreement. You agree that you will not disclose to others the existence or terms of
this Agreement, except that you may disclose such information to your spouse, attorney or tax adviser if such individuals agree that they will not disclose to others the existence or terms of this Agreement. 

 

	 	12.	 No Disparagement. You agree that you will never make any negative or disparaging statements (orally or
in writing) about the Company or its stockholders, directors, officers, employees, products, services or business practices, except as required by law.  

 

	 	13.	 Company Property. You represent that you have returned to the Company all property that belongs to the
Company, including (without limitation) copies of documents that belong to the Company and files stored on your computer(s) that contain information belonging to the Company. 

 

	 	14.	 Severability. If any term of this Agreement is held to be invalid, void or unenforceable, the remainder
of this Agreement will remain in full force and effect and will in no way be affected, and the parties will use their best efforts to find an alternate way to achieve the same result. 

 

	 	15.	 Choice of Law. This Agreement will be construed and interpreted in accordance with the laws of the
Commonwealth of Massachusetts (other than their choice-of-law provisions). 

  

	 	16.	 Execution. This Agreement may be executed in counterparts, each of which will be considered an original,
but all of which together will constitute one agreement. Execution of a facsimile copy will have the same force and effect as execution of an original, and a facsimile signature will be deemed an original and valid signature. 

 Dr. Kennedy 
 
Page
 4
 
  

 Please indicate your agreement with the above terms by signing below. 

 

			
	Very truly yours,
	
	 HISTOGENICS CORPORATION 

		
	By:	 	 /s/ Adam Gridley

			
	Name:	 	 Adam Gridley

	 Title:
	 	 President and Chief Executive Officer 

 I agree to the terms of this Agreement, and I am voluntarily signing this release of all claims. I
acknowledge that I have read and understand this Agreement, and I understand that I cannot pursue any of the claims and rights that I have waived in this Agreement at any time in the future. 

 

									
					
	 Signed:
	 	 /s/ Stephen Kennedy
	 		 	 Dated:
	 	 March 19, 2019

		 	 Stephen Kennedy 
	 		 		 	

 Dr. Kennedy 
 
Page
 5
 
  

 EXHIBIT A 

CONSULTING AGREEMENT 

 Dr. Kennedy 
 
Page
 6
 
  

 EXHIBIT B 

PROPRIETARY INFORMATION, INVENTIONS AND 

NON-SOLICITATION AGREEMENTExhibit 10.12

 

EXECUTION VERSION

 

DIAMOND S SHIPPING INC.

33 Benedict Place

Greenwich, CT 06830

 

May 14, 2019

 

Nordea Bank Abp, New York Branch, as Administrative Agent

1211 Avenue of Americas

New York, New York 10036

 

	 	Amendment Letter:	US $360,000,000 Credit Agreement

 

Ladies and Gentlemen:

 

Reference is made to that
certain credit agreement dated as of March 27, 2019 (the “Credit Agreement”), providing for a term loan facility
and a revolving loan facility made by and among, inter alios, (i) Diamond S Shipping Inc., a company organized under the
laws of the Republic of the Marshall Islands, as borrower (the “Borrower”), (ii) the banks, financial institutions
and other institutional lenders listed on the signature pages thereof, as lenders (the “Lenders”) and (iii)
Nordea Bank Abp, New York Branch, as administrative agent and collateral agent (together with any successor administrative agent
and collateral agent appointed pursuant to Section 10 of the Credit Agreement, the “Administrative Agent” or
as applicable, the “Collateral Agent”) for the Secured Creditors. Unless otherwise expressly defined herein,
terms which are defined in the Credit Agreement have the same meaning when used herein.

 

We hereby request that
an amendment be made to the Credit Agreement, pursuant to which the amendments set forth below under the heading “Amendments
to the Credit Agreement” will be made. Kindly indicate your acceptance and agreement with the foregoing provisions of this
amendment letter (the “Amendment Letter”) by executing this Amendment Letter in the space indicated below.

 

This Amendment Letter shall
become effective on the date (the “Amendment Effective Date”) when the Required Lenders shall have signed a
counterpart hereof and shall have delivered the same to the Administrative Agent.

 

Amendments to the Credit Agreement.

 

Upon the Amendment Effective
Date, and subject to the occurrence thereof, the Credit Agreement shall be amended to reflect the following:

 

(a)       Schedule
X (Scheduled Term Loan Amortization Payment Amount) of the Credit Agreement shall be deleted in its entirety and replaced
with the new Schedule X attached hereto.

 

(b)       The
definition of “Payment Date” appearing in Section 1.01 of the Credit Agreement shall be amended and restated in its
entirety and replaced with the following definition:

 

““Payment
Date” shall mean the last Business Day of each September, December, March and June, commencing with September 30, 2019,
as set forth on Schedule X hereto.”.

 

(c)       The
definition of “Scheduled Term Loan Amortization Payment Amount” appearing in Section 1.01 of the Credit Agreement shall
be amended and restated in its entirety and replaced with the following definition:

 

     

     

    

 

““Scheduled
Term Loan Amortization Payment Amount” shall mean for any Payment Date, $13,750,000.00, as such amount may be reduced
from time to time pursuant to Section 4.02(d). The Scheduled Term Loan Amortization Payment Amount for each Payment Date as of
the Closing Date is set forth on Schedule X.”.

 

(d)       Clause
7.12(b) of the Credit Agreement shall be deleted in its entirety and replaced with the following new language:

 

“(b) Notwithstanding
the requirements set forth in clause (a), Earnings for the Collateral Vessels described in Part 1 of Schedule VI shall be permitted
to be deposited into one or more deposit accounts held by a Collateral Vessel Owner at Hamburg Commercial Bank (“HCB”),
ING Bank N.V. (“ING”) and/or Credit Agricole Corporate and Investment Bank (“CACIB”), which
Earnings are payable in connection with charter agreements and other contracts of employment for such Collateral Vessels existing
on the Closing Date; provided that, (A) with respect to the deposit accounts held by the Collateral Vessel Owners at HCB and CACIB,
(x) not later than May 31, 2019, each relevant Collateral Vessel Owner shall have provided evidence to the Administrative Agent
that the signatories on such accounts are Authorized Officers of such Collateral Vessel Owners and (y) not later than May 31, 2019
(subject to extensions to be reasonably agreed upon by the Administrative Agent), (i) each relevant Collateral Vessel Owner shall
have executed and delivered an account pledge agreement over the relevant accounts at HCB and CACIB pursuant to documentation in
form and substance reasonably acceptable to the Required Lenders (each, an “Additional Account Pledge Agreement”),
(ii) each relevant Collateral Vessel Owner shall have closed such accounts and all amounts on deposit transferred to an Earnings
Account and/or (iii) each relevant Collateral Vessel Owner shall have entered into other arrangements for amounts on deposit in
such accounts to be periodically swept into an Earnings Account pursuant to documentation satisfactory to the Required Lenders
and (B) with respect to the deposit accounts held by the relevant Collateral Vessel Owner at ING, not later than May 31, 2019 (subject
to extensions to be reasonably agreed upon by the Administrative Agent), such Collateral Vessel Owner shall close such deposit
accounts.”.

 

Miscellaneous Provisions.

 

In order to induce the
Lenders to enter into this Amendment Letter, the Borrower hereby represents and warrants (on behalf of itself and the other Credit
Parties) that (i) no Default or Event of Default exists on the Amendment Effective Date both before and after giving effect to
this Amendment Letter and (ii) all of the representations and warranties contained in the Credit Agreement or the other Credit
Documents are true and correct in all material respects on the Amendment Effective Date after giving effect to this Amendment Letter,
with the same effect as though such representations and warranties had been made on and as of the Amendment Effective Date (it
being understood that any representation or warranty made as of a specific date shall be true and correct in all material respects
as of such specific date).

 

This Amendment Letter is
limited precisely as written and shall not be deemed to (i) be a waiver of or a consent to the modification of or deviation from
any other term or condition of the Credit Agreement or any other Credit Document or (ii) prejudice any right or rights which any
of the Lenders or the Agents now have or may have in the future under or in connection with the Credit Agreement or the Credit
Documents.

 

THIS AMENDMENT LETTER
AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE CONSTRUED IN ACCORDANCE WITH AND BE GOVERNED BY THE LAW OF THE
STATE OF NEW YORK. The following provisions of the Credit Agreement are incorporated herein by reference, mutatis mutandis:
Sections 11.01 (Payment of Expenses, etc.), 11.08 (Agreement Binding), 11.10 (Counterparts; Integration) and 11.21 (Severability).

 

     

     

    

 

From and after the Amendment
Effective Date, all references in the Credit Agreement and each of the other Credit Documents to the Credit Agreement shall be
deemed to be references to the Credit Agreement, as modified hereby. This Amendment Letter shall constitute a Credit Document.

 

[Signature pages follow]

 

     

     

    

 

	Very truly yours,	 
	 	 
	DIAMOND S SHIPPING INC.	 
	 	 
	By:	 /s/ Kevin Kilcullen	 
	Name: 	Kevin Kilcullen	 
	Title: 	Chief Financial Officer	 

 

[US $360,000,000 Credit Agreement Amendment
Request]

 

     

     

    

 

	CONSENTED TO AND AGREED this 14th day of May, 2019	 
	 	 
	NORDEA BANK ABP, NEW YORK BRANCH,	 
	as Administrative Agent, Collateral Agent and Lender	 
	 	 
	By: 	/s/ Martin Lunder	 
	Name: 	Martin Lunder	 
	Title: 	Managing Director	 
	 	 
	By:	 /s/ Lynn Sauro	 
	Name: 	Lynn Sauro	 
	Title: 	Director	 

 

	SKANDINAVISKA ENSKILDA BANKEN AB (PUBL),	 
	as Lender	 
	 	 
	By:	 /s/ Helene Hellners	 
	Name: 	Helene Hellners	 
	Title:	 	 
	 	 
	By: 	/s/ Sari Kahelin	 
	Name:	 Sari Kahelin	 
	Title: 	 	 

 

	CRÉDIT AGRICOLE CORPORATE AND INVESTMENT BANK,	 
	as Lender	 
	 	 
	By: 	/s/ Manon Didier	 
	Name: 	Manon Didier	 
	Title: 	Vice President	 
	 	 
	By:	/s/ George Gkanasoulis	 
	Name: 	George Gkanasoulis	 
	Title: 	Director	 

 

[US $360,000,000 Credit Agreement Amendment
Request]

 

     

     

    

 

	NATIONAL AUSTRALIA BANK LIMITED,	 
	as Lender	 
	 	 
	By: 	/s/ Daniel Carr	 
	Name: 	Daniel Carr	 
	Title: 	Director	 
	 	 
	By: 	/s/ Matt Richardson	 
	Name: 	Matt Richardson	 
	Title: 	Associate Director	 

 

[US $360,000,000 Credit Agreement Amendment
Request]

 

     

     

    

 

SCHEDULE X

 

SCHEDULED TERM LOAN AMORTIZATION PAYMENT
AMOUNT

 

	Payment Date	 	Scheduled Term Loan Amortization Payment 

Amount
	September 30, 2019	 	US$ 13,750,000.00
	December 31, 2019	 	US$ 13,750,000.00
	March 31, 2020	 	US$ 13,750,000.00
	June 30, 2020	 	US$ 13,750,000.00
	September 30, 2020	 	US$ 13,750,000.00
	December 31, 2020	 	US$ 13,750,000.00
	March 31, 2021	 	US$ 13,750,000.00
	June 30, 2021	 	US$ 13,750,000.00
	September 30, 2021	 	US$ 13,750,000.00
	December 31, 2021	 	US$ 13,750,000.00
	March 31, 2022	 	US$ 13,750,000.00
	June 30, 2022	 	US$ 13,750,000.00
	September 30, 2022	 	US$ 13,750,000.00
	December 31, 2022	 	US$ 13,750,000.00
	March 31, 2023	 	US$ 13,750,000.00
	June 30, 2023	 	US$ 13,750,000.00
	September 30, 2023	 	US$ 13,750,000.00
	December 31, 2023	 	US$ 13,750,000.00
	Maturity Date	 	US$ 52,500,000.00

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}]]